4-(6-acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric acid,
KCA 757,
KCA-757,
KCA757,
MN 001,
MN-001,
MN001 cpd,
Tipelukast,
125961-82-2,
KCA 757,
KCA-757,
UNII-08379P260O,
MN-001 (Tipelukast),
08379P260O,
Butanoic acid,4-[6-acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)thio]propoxy]-2-propylphenoxy]-,
Tipelukast [USAN:INN],
MN 001 (pharmaceutical),
KCA757,
4-(6-Acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric acid,
4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid,
Butanoic acid, 4-(6-acetyl-3-(3-((4-acetyl-3-hydroxy-2-propylphenyl)thio)propoxy)-2-propylphenoxy)-,
Butanoic acid, 4-[6-acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)thio]propoxy]-2-propylphenoxy]-,
MN 001,
Tipelukast (USAN),
ACMC-20mrr5,
SCHEMBL154898,
CHEMBL2104988,
CTK4B4879,
KPWYNAGOBXLMSE-UHFFFAOYSA-N,
BCP17000,
ZINC3796820,
AKOS015914770,
CS-6822,
DB12435,
SB17439,
AN-32660,
HY-14938,
D06659,
961T822,
L001366,
I14-41563,
4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propyl-phenyl)sulfanylpropoxy]-2-propyl-phenoxy]butanoic acid,
4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propyl-phenylthio)propoxy]-2-propylphenoxy]butyric acid,
4-[6-Acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)sulfanyl]propoxy]-2-propylphenoxy]butanoic acid,
Asthma therapy, MediciNova,
D0Q7UG,
MN-001,
CID9893228,
CID 9893228,